Home >> News >> Business >> Global Endocrine Testing Market to Reach Worth US$ 7,359.4 Mn by 2025

Global Endocrine Testing Market to Reach Worth US$ 7,359.4 Mn by 2025

Market Insight:

The endocrine systems is a setup of glands that produce and secrete hormones, vital for regulating metabolism, sexual development, body growth and other vital functions. Endocrine testing assists in determining the functioning of the endocrine glands through assessment of hormonal levels. The global endocrine testing market is driven by increasing incidence of hormonal imbalances in individuals across all age groups. Such increase in disease incidence has resulted in development of advanced diagnostic technologies thus increasing the demand for sophisticated testing methods. However, it is anticipated that significant costs involved in development of advanced testing techniques may hold back rapid commercialization of these technologies in the market, thereby restrain the market growth.

Among the various test types used in endocrine diagnostics, insulin testing and thyroid stimulating hormone test will account for the largest market share throughout the forecast period. High incidence of hyper- and hypothyroidism and increasing prevalence of diabetes are the key drivers of these segments. Additionally, being chronic in nature, these diseases demand periodic monitoring through testing methods, and at higher frequencies. This fact will ensure the dominance of these segments during the forecast period.

Based on the type of disorders, the endocrine testing market is segmented into adrenal disorders, calcium problems, glucose (islet cells) disorders, male and female gonadal problems, heart disorders, hypertensive disorders, thyroid disorders, and pituitary disorders. Among these, glucose disorders and thyroid disorders capture the highest revenue share, mainly contributed by high prevalence of these diseases. On the other hand, it is expected that diagnosis for male and female gonadal problems and heart disorders will witness the fastest growth during the forecast period on the ground of technological advancement in diagnostic techniques, enhancing their accuracy and steady rise in the incidence of the respective conditions.

On the basis of testing techniques, the global endocrine testing market is categorized into immunoassay technology, tandem mass spectrometry, sensors technology, monoclonal and polyclonal antibody technology, clinical chemistry technology and others. Tandem mass spectrometry is anticipated to witness the fastest growth during the forecast period, closely corresponded by growing accuracy of this technique and increasing application areas. The usage of endocrine testing is currently the highest in clinical laboratories and it is estimated that the same trend will continue through the forecast period.

Geographically, North America currently leads the global endocrine testing market, in terms of revenue generation. High incidence of several types of endocrine diseases, swift adoption of novel testing techniques supported by regulatory infrastructure and positive reimbursement scenario mainly contribute to the dominance of North America on the global front. Asia Pacific is observed to be the fastest progressing regional market for endocrine testing. Changes in lifestyle leading to increasing prevalence of chronic diseases and huge target population base are the prime drivers of Asia Pacific market.

Some of the market players currently enjoying prominent position in the field of endocrine testing include Abbott Laboratories, AB Sciex Pte Ltd., Agilent Technologies, Inc., Biomedical Technologies (Alfa Aesar), bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Ortho-clinical Diagnostics, Quest Technology Pte Ltd., Sysmex Corporation and Teleflex Incorporated.

“Endocrine Testing Market” is a new report by us that explains how companies’ acquisition expenditures, media spend, business strategies, marketing and sales strategies and practices, and business plan are set to change in 2017-2018. This paper gives you access to the category-level spending forecasts, business challenges, budgets, supplier selection criteria, the current size of the marketing and promotion budgets and investment opportunities for senior-level officials. The report also identifies the expected growth of buyers and suppliers, capital expenditure, staff hiring, M and A, and e-procurement. This report not only gives access to the views and strategies of business decision makers and rivals but also examines their actions circling business priorities. The report also provides access to information categorized by company type and sizes, region,

Introduction and Landscape

Company Profiles
9.1 Abbott Laboratories, Inc.
9.2 Agilent Technologies
9.3 bioMerieux S.A.
9.4 Bio-Rad Laboratories, Inc.
9.5 DiaSorin S.p.A.
9.6 F. Hoffmann-La Roche AG
9.7 Ortho Clinical Diagnostics
9.8 SCIEX (Danaher Corporation)
9.9 Siemens AG
9.10 Thermo Fisher Scientific, Inc.

Why was the report written?

This report is the result of an extensive survey drawn from Our Research’s elite panel of leading global senior level executives from enterprises such as such as medical devices, mining, packaging, power, oil, and gas, food and beverage, airports and pharmaceutical. The report covers key topics such as appropriation behaviors and strategies, the current size of the marketing and advertising budgets. Besides the report also recognizes the threats and possibilities, economic outlook trends, media channel spending outlooks, M and A expectations, marketing agency selection models, media budgets, business challenges and confidence among senior-level executives across various industries. Most secondary research papers are based on general industry drivers and do not understand the industry officials’ attitude and changing behaviors, creating a gap in showing the business opportunity of the industry. In an effort to bridge this gap, Our Research created this primary-research based report by selecting the opinions of various stakeholders in the value-chain of the industry

This report offers:

  • Analysis of several products, and regions that would provide the clear understanding of the ongoing and future trends in the global Endocrine Testing market
  • Assessment of market dynamics such as drivers, restraints, and opportunities prevalent in the market
  • Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
  • Company profiles that will highlight key information about the imperative players operating in the global Endocrine Testing devices market

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/58725

About us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in the Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Email:

sales@credenceresearch.com

http://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *